December 1, 2017 Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
January 1, 2017 Evaluating the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Results from the quantitative pilot study
Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
January 12, 2016 Interpretation of verbal descriptors for response options commonly used in verbal rating scales in patient-reported outcome instruments
April 11, 2016 Electronic Capture of Clinical Outcome Assessment Data: Why Is It Not Used More in Clinical Studies
CDISC, C-Path, and TransCelerate Announce Therapeutic Area Standard for Kidney Transplant November 2, 2016 CDISC, C-Path, and TransCelerate Announce Therapeutic Area Standard for Kidney Transplant TUCSON, A
US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract November 1, 2016 US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract TUCSON, A